Private Health Insurance
- Report
The Estimated Effects of Enacting Selected Health Coverage Policies on the Federal Budget and on the Number of People With Health Insurance
CBO estimates that permanently extending the expanded premium tax credit, nullifying a marketplace final rule, and repealing policies in the 2025 reconciliation act would increase deficits and the number of people with health insurance.
- Report
Growth in the 340B Drug Pricing Program
CBO examines drug purchases made through the 340B program in 2021, growth in such purchases from 2010 to 2021, and factors that contributed to that growth. CBO also assesses how the 340B program affects the federal budget.
- Report
Clarifications of Marketplace Coverage and Eligibility Under Public Law 119-21 (H.R. 1) and the 2025 Marketplace Integrity and Affordability Rule
CBO provides information about the effects of P.L. 119-21 (H.R. 1) on health insurance purchased through the ACA marketplaces and on improper receipt of subsidies, and the effects of a final rule published by HHS on marketplace subsidies.
- Report
How Increased Use of Gene Therapy Treatment for Sickle Cell Disease Could Affect the Federal Budget
Gene therapies replace or modify disease-causing genes in human cells. In this report, CBO discusses how it would estimate the budgetary effects of policies that sought to increase the use of gene therapy treatment for sickle cell disease.
- Report
Options for Reducing the Deficit: 2025 to 2034
CBO periodically issues a compendium of policy options and their estimated effects on the federal budget. This report presents 76 options for altering spending or revenues to reduce federal budget deficits over the next decade.
- Cost Estimate
S. 1339, Pharmacy Benefit Manager Reform Act
As reported by the Senate Committee on Health, Education, Labor, and Pensions on June 22, 2023
- Report
The Effects of Not Extending the Expanded Premium Tax Credits for the Number of Uninsured People and the Growth in Premiums
CBO provides estimates on how not extending the expanded premium tax credit will affect the number of people without health insurance and average gross benchmark premiums for plans purchased through the marketplaces.
- Report
Alternative Approaches to Reducing Prescription Drug Prices
CBO discusses prescription drug prices and approaches aimed at reducing those prices. Some of the approaches would cap prices or limit their growth, and other approaches would promote price competition or affect the flow of information.
- Report
Answers to Questions for the Record Following a Hearing on Hospital and Physician Consolidation and Its Impact on the Federal Budget
The House Committee on the Budget convened a hearing at which Chapin White, CBO's Director of Health Analysis, testified. This document provides CBO’s answers to questions submitted for the record.
- Report
The Effects of Permanently Extending the Expansion of the Premium Tax Credit and the Costs of that Credit for Deferred Action for Childhood Arrivals Recipients
CBO provides information about the effects on the budget and on health insurance coverage of permanently extending the expanded premium tax credit and about the costs of that credit for Deferred Action for Childhood Arrivals recipients.